Fulgent Genetics (NASDAQ:FLGT) is preparing to release its quarterly earnings on Friday, 2025-05-02. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...
7 analysts have shared their evaluations of Myriad Genetics (NASDAQ:MYGN) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ...
Precision medicine -> the practice of treating diseases using insights gained from sequencing the human genome is an increasingly popular term, even in mainstream media. This innovative field offers ...
Revenue was $19.5 million, up 23% year-over-year Gross margin was 66.3% on a reported basis and 73.1% on an adjusted basis, compared to 67.2% reported and 73.1% adjusted in the prior year period Net ...
The race for more data is dominating the wellness industry. More people are tracking their sleep, monitoring their glucose levels, and analyzing their step count as a way to optimize, or even gamify, ...
Largest genetic study to date marks a turning point, as researchers uncover the genetic roots of anxiety disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results